Streamlining the clinical trials management process in Spain could attract more international clinical trials to the country, providing economic benefits. Calculations estimated that streamlining activation procedures could increase the number of international clinical trials in Spain by 8% annually, attracting over 137 new trials in 3 years. This could generate 140 million euros in economic impact and create 452 new jobs, while also providing 8,000 patients early access to innovative treatments. Improving management processes could provide Spain a competitive advantage to participate in more global clinical research.